AI assistant
TYRO PAYMENTS LIMITED — Director's Dealing 2023
Nov 22, 2023
65973_rns_2023-11-22_6c03a366-7b02-46ce-a43d-ee18d938d566.pdf
Director's Dealing
Open in viewerOpens in your device viewer
APPENDIX 3Y – JON DAVEY
Sydney, 23 November 2023 – Tyro Payments Limited ( Tyro ) has today released an Appendix 3Y relating relating to a change of Director’s Interest by Jon Davey. The Appendix 3Y is attached to this announcement.
For further information, please contact:
Media: Gemma Garkut Ph: +61 422 040 559 E: [email protected]
Investors: Giovanni Rizzo Ph: +61 439 775 030 E: [email protected]
Pursuant to Listing Rule 15.5, Tyro confirms this document has been authorised for release to the market by its CEO and Managing Director.
About Tyro - Tyro is a technology-focused and values-driven Group providing Australian businesses with payment solutions and valueadding business banking products. The Group provides simple, flexible and reliable payment solutions as a merchant acquirer, along with complementary business banking products. More than 68,500 Australian merchants chose to partner with Tyro as at 30 June 2023. The Group processed $42.6 billion in transaction value in FY23 and generated $193.2 million in normalised gross profit, originated a record $149.7 million in loans and held merchant deposits totaling $92.7 million. Tyro is Australia’s fifth largest merchant acquiring bank by number of terminals in the market, behind the four major banks.
The business was founded in 2003 with a goal of being the most efficient acquirer of electronic payments in Australia. Tyro has a track record of innovation, creating purpose-built solutions and being first to market. This approach saw the company become the first technology company to receive an Australian specialist credit card institution licence in 2005. In 2015 that licence was replaced by the award of an Australian banking licence, making Tyro the first new domestic banking licensee in over a decade.
Payments are at the core of Tyro’s business, using its proprietary core technology platform to enable credit and debit card acquiring. This offering is enhanced by features purpose-designed for those merchants who choose to partner with the company, including Point of Sale systems integrations, least-cost routing (Tap & Save) and alternative payment types such as integrated Alipay. While traditionally focused on in-store payments, Tyro has recently expanded into eCommerce. Further, Tyro provides value-adding solutions to its partners, such as loans in the form of merchant cash advances and fee-free, interest-bearing merchant transaction accounts.
Tyro has a team of approximately 600 employees, with ~80% of team members working in Technology, Solution, Design and Delivery and Growth teams, focused on delivering solutions for our customers.
==> picture [77 x 11] intentionally omitted <==
A 18/55 Market Street, Sydney NSW 2000 T +61 2 8907 1700 E [email protected] W tyro.com ACN 103 575 042 AFSL 471951 (Tyro) is the issuer of its own financial products L\347976976.1
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity. Tyro Payments Limited ABN 49 103 575 042
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Jonathan Charles Davey |
|---|---|
| Date of last notice | 1 September 2023 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct and indirect. |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
Refer below. |
| Date of change | 16 November 2023 |
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held prior to change | Direct interests: • 1,282,051 FY23 LTI Performance Rights convertible into fully paid Ordinary Shares. • 297,619 Medipass Service Rights convertible into fully paid Ordinary Shares. • 297,619 Medipass Performance Rights convertible into fully paid Ordinary Shares. • 25,314 FY22 Rights convertible into fully paid Ordinary Shares. • 36,082 FY22 LTI Rights convertible into fully paid Ordinary Shares. Indirect interests: • 471,148 Ordinary Shares held in escrow in an employee share trust subject to the repayment of a loan granted to the employee. |
|
|---|---|---|
| Class | TYRAA – Performance Rights | |
| Number acquired | • 159,576 FY23 STI Equity Rights (vesting equally over a 12-month period from grant). • 159,577 FY23 STI Equity Rights (vesting in a single tranche 4-years from grant). |
|
| Number disposed | Nil | |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
Nil |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held after change | Direct interests: • 1,282,051 FY23 LTI Performance Rights convertible into fully paid ordinary shares. • 297,619 Medipass Service Rights convertible into fully paid ordinary shares. • 297,619 Medipass Performance Rights convertible into fully paid ordinary shares. • 25,314 FY22 Rights convertible into fully paid ordinary shares. • 36,082 FY22 LTI Rights convertible into fully paid ordinary shares. • 159,576 FY23 STI Equity Rights (vesting equally over a 12-month period from grant). • 159,577 FY23 STI Equity Rights (vesting in a single tranche 4-years from grant). Indirect interests: • 471,148 Ordinary Shares held in escrow in an employee share trust subject to the repayment of a loan granted to the employee. |
|
|---|---|---|
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back |
Rights issued relating to the FY23 STI plan as approved by Shareholders at the 2023 AGM. |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | Medipass Solutions Pty Ltd (a wholly owned subsidiary of Tyro Payments Ltd agreed to loan Jonathan Davey an amount of $1,000,787.04 (Loan) to acquire 471,148 shares in Tyro Payments Limited. These shares are currently held by Pacific Custodians Pty Ltd (as trustee for Medipass Employee Share Trust) |
|---|---|
| Nature of interest | Party to loan agreement. |
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 3
Appendix 3Y Change of Director’s Interest Notice
| Name of registered holder (if issued securities) |
Pacific Custodians Pty Limited (as trustee for Medipass Employee Share Trust) |
|---|---|
| Date of change | N/A |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed |
471,148 |
| Interest acquired | N/A |
| Interest disposed | N/A |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation |
N/A |
| Interest after change | N/A |
Part 3 –[+] Closed period
| Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required? |
No |
|---|---|
| If so, was prior written clearance provided to allow the trade to proceed during this period? |
|
| If prior written clearance was provided, on what date was this provided? |
- See chapter 19 for defined terms.
Appendix 3Y Page 4
01/01/2011